Antibacterial activity of Aloe vera extract and chitosan nanoparticles against Porphyromonas gingivalis and fibroblast viability assay analysis
DOI:
https://doi.org/10.51094/jxiv.368Keywords:
antibacterial activity, aloe vera extract, chitosan nanoparticles, porphyromonas gingivalis, fibroblast cell viabilityAbstract
The use of herbal medicine as an alternative therapy to reduce periodontal inflammation is then being developed to resolve antibiotic resistance. Aloe vera is receiving much scientific attention, but herbal drug formulation has limitations. The efficiency of herbal medicines can improve with a drug delivery system utilizing chitosan nanoparticles. This research aims to develop a potential antibiotic combining Aloe vera extract and chitosan nanoparticles. Evaluate their antibacterial activity against P.gingivalis and toxicity on BHK-21 fibroblast cells. Determining Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values used the microdilution method in 96 well plates. ELISA did a viability assay. The MIC and MBC were obtained in concentrations of 80% Aloe vera – 25% chitosan nanoparticles. A combination of 80% Aloe vera extract and various chitosan nanoparticle formulations had a greater inhibitory zone than a single sample used. Combining these two materials showed potent antibacterial activity and was not toxic.
Conflicts of Interest Disclosure
no conflict of interests regarding the publication of this article.Downloads *Displays the aggregated results up to the previous day.
References
Mombelli A, Samaranayake L. Topical and systemic antibiotics in the management of periodontal diseases. International Dental Journal 2004; 54: 3–14.
Lestari E, Severin J, Verbrugh H. Antimicrobial Resistance Among Pathogenic Bacteria in Southeast Asia.
Southeast Asian J Trop Med Public Health 2012; 43: 8-15.
Saraf A.S. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010; 81: 680–689.
Subbiah U, Elango S, Jayesh R. Herbals and green synthesized nanoparticles in dentistry. Nanobiomaterials in Clinical Dentistry 2019; 10: 617–646.
Cheung W.H, Szeto Y. S, McKay G. Enhancing the adsorption capacities of acid dyes by chitosan nano particles. Bioresource Technology 2009; 100: 1143–1148.
Mohanraj V. J, Chen Y. Nanoparticles - A review. Tropical Journal of Pharmaceutical Research 2006; 5: 561-573.
Rafiei M, Kiani F, Sayehmiri F. Study of Porphyromonas gingivalis in periodontal diseases: A systematic review and meta-analysis. Med J Islam Republic Iran 2017; 31: 355–362.
Khare T, Anand U, Dey A, Assaraf Y.G, Chen Z, Liu Z. Exploring Phytochemicals for Combating Antibiotic
Resistance in Microbial Pathogens. Front Pharmacol J 2021; 12: 720-726
Mercado N, Bhatt P, Sutariya V, Florez F, Pathak Y. Application of Nanoparticles in Treating Periodontitis:
Preclinical and Clinical Overview in Surface Modification of Nanoparticles for Targeted Drug Delivery. Springer
Andres Y, Giraud L, Gerente C, Le Cloirec P. Antibacterial Effects of Chitosan Powder: Mechanisms of Action. Environmental Technology 2007; 28: 1357–1363.
Sánchez M, González-Burgos E, Iglesias I, Gómez-Serranillos M. Pharmacological Update Properties of Aloe Vera and its Major Active Constituents. Molecules 2020; 25: 13-24.
Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. International Journal of Pharmaceutics 2003; 250: 215–226 International Publishing 2019; 5: 467-480.
Downloads
Posted
Submitted: 2023-04-20 17:31:23 UTC
Published: 2023-04-28 00:41:40 UTC
License
Copyright (c) 2023
Pratidina Fitri Ramadhani
Sri Lelyati C Masulili
Robert Lessang
Yuniarti Soeroso
Natalina
Ette Soraya Tadjoedin
Padmini Hari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
